| Literature DB >> 33954822 |
Tom I Bootsma1,2, Melanie P J Schellekens3,4, Rosalie A M van Woezik3, Jenny Slatman5, Marije L van der Lee3,4.
Abstract
PURPOSE: The growing group of patients who suffer from chronic cancer-related fatigue (CCRF) after cancer have helpful and less helpful ways of responding to this long-lasting and disruptive problem. This qualitative study aimed to gain insight in essential elements of how patients respond to CCRF, with a focus on helpful responses to facilitate adaptation.Entities:
Keywords: Cancer; Chronic cancer-related fatigue; Habits; Interpretative phenomenological analysis; Qualitative research; Survivorship
Mesh:
Year: 2021 PMID: 33954822 PMCID: PMC8464573 DOI: 10.1007/s00520-021-06252-3
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603
Participants’ characteristics (N = 25)
| Characteristic | Value |
|---|---|
| Female/male gender ( | 16/9 |
| Age at interview (years; mean ± SD, range) | 52.64 ± 12.86 (21–80) |
| In a relationship ( | 23 |
| Children at home ( | 11 |
| Education level ( | |
| -Low | 3 |
| -Intermediate | 13 |
| -High | 9 |
| Currently employed ( | |
| -Job | 10 |
| -(Partial) disabled | 8 |
| -No job/household | 4 |
| -Retired | 2 |
| -Scholar or student | 1 |
| Type of cancer(s) ( | |
| -Breastc | 10 |
| -Hematologicald | 8 |
| -Digestive system | 5 |
| -Head or neck | 2 |
| -Male genitalia | 2 |
| -Urinary tract | 2 |
| -Bone or soft tissue | 1 |
| -Brain and central nervous system | 1 |
| -Skin | 1 |
| -Gynecological | 1 |
| Treatment(s) ( | |
| -Surgery | 20 |
| -Chemotherapy | 18 |
| -Radiotherapy | 15 |
| -Hormonal therapy | 6 |
| -Immunotherapy | 2 |
| -Bone marrow transplantation | 1 |
| Metastasis ( | 7 |
| Comorbidities ( | 12 |
| Months since first diagnosis interview, (M ± SD, range) | 56.88 ± 45.11 (11–169) |
| Months since last treatment interview, (M ± SD, range) | 43.72 ± 35.96 (6–159) |
| Checklist Individual Strength (CIS)f, (M ± SD, range) Score subscale: fatigue severity (FS) | 43.0 ± 5.02 (35–52) |
| Hospital Anxiety and Depression Scale (HADS)f (M ± SD, range) score | 13.84 ± 5.39 (4–23) |
| Duration of severe fatigue ( | |
| -3–5 months | 1 |
| -6–12 months | 6 |
| -1–2 years | 6 |
| -2–5 years | 7 |
| - > 5 years | 5 |
| Prior professional support for cancer ( | 18 |
aLow = primary/lower secondary education; intermediate = upper secondary education; high = higher vocational training/university.
bNumbers do not add up to 25 because multiple options are possible.
cOne participant had another type of breast cancer for the second time and was counted twice.
dOne participant had two different hematological diseases and was counted twice.
eComorbidities: diabetes, spine condition, pelvic disease, lung disease (asthma, bronchitis, or CARA), thyroid disease, liver disease, ulcerative colitis, graft versus host disease, sleep apnea, neuropathic sensations, vertigo, tinnitus, PTSS, neurological disease, migraine, and inflammatory bowel disease.
fBaseline data T0a FNK trial.
gProfessional support: revalidation, general practitioner, spiritual counsellor, social worker, psychologist, institute for mental health care, institute for psycho-oncology, psychosomatic exercise therapy, physiotherapy, and lifestyle program.
Themes of responding to CCRF
| 1. Discovering physical and emotional boundaries |
| “ |
| 2. Communicating support needs |
| “ |
| 3. Reorganizing and planning activities and rest |
| “ |
| 4. Letting go of one’s habitual identity |
| “ |
| 5. Recognizing and accepting CCRF |
| “ |